Encorafenib and Binimetinib: A New Treatment Option for BRAF(V600E)-Mutant Non-Small-Cell Lung Cancer. Stinchcombe TE. J Clin Oncol 2023 Jun 4:JCO2300983. doi: 10.1200/JCO.23.00983.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stinchcombe TE. Encorafenib and Binimetinib: A New Treatment Option for BRAF(V600E)-Mutant Non-Small-Cell Lung Cancer. J Clin Oncol 2023 Jun 4:JCO2300983. doi: 10.1200/JCO.23.00983.
PMID: 37270690